Medical management of endometriosis

Kathleen G. Waller; Robert W. Shaw

doi:10.1016/0957-5847(93)90005-a

Medical management of endometriosis

Kathleen G. Waller, Robert W. Shaw

In: Current Obstetrics & Gynaecology · 1993 · vol. 3(3) , pp. 139–144 · doi:10.1016/0957-5847(93)90005-a · W2055732687

article OA: closed CC0

Limited metadata. Only one source feed has indexed this record so far — no abstract, full text, or open-access copy is available through Endo Lab. The publisher's page (linked below) is the canonical location for the actual content. If you have institutional access, use "Find at my library".

View at publisher → View on OpenAlex

⚙ AI-generated summary by claude@2026-06, 2026-06-06 ⓘ

This paper reviews the medical management of endometriosis, discussing various treatment options and their effectiveness.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (48)

10 LHRH analogues in the treatment of endometriosis—comparative results with other treatments via openalex
A comparison of nafarelin acetate and danazol in the treatment of endometriosis via openalex
A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens* via openalex
A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group. via openalex
Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis via openalex
Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: A randomized clinical trial via openalex
Comparison of different treatment modalities of endometriosis in infertile women via openalex
Comparison of different treatment modalities of endometriosis in infertile women. via openalex
Conservative management of endometriosis: follow-up observations of progestin therapy. via openalex
Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosis via openalex
Deficient cellular immunity in endometriosis via openalex
DYDROGESTERONE AND ENDOMETRIOSIS via openalex
Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. via openalex
Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex
Impact of gestrinone on the course of asymptomatic endometriosis. via openalex
Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. via openalex
Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists? via openalex
Leuprorelin acetate depot vs danazol in the treatment of endometriosis: results of an open multicentre trial. via openalex
MANAGEMENT OF ENDOMETRIOSIS WITH ORAL MEDROXYPROGESTERONE ACETATE via openalex
Management of pelvic endometriosis with low-dose danazol via openalex
Management of Pelvic Endometriosis with Low-Dose Danazol via openalex
“MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex
Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis via openalex
Preliminary observations on the use of danazol in endometriosis compared to oestrogen/progestogen combination therapy. via openalex
Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial via openalex
Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex
REVERSIBLE TRABECULAR BONE DENSITY LOSS FOLLOWING INDUCED HYPO‐OESTROGENISM WITH THE GnRH ANALOGUE BUSERELIN IN PREMENOPAUSAL WOMEN via openalex
Some clotting factors in plasma during danazol therapy: free and total protein S, but not C4b-binding protein, are elevated by danazol therapy. via openalex
Successful treatment of asymptomatic endometriosis: does it benefit infertile women? via openalex
The effect of danazol on pulsatile gonadotropin secretion in women with endometriosis via openalex
The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
The effects of combining norethindrone with a gonadotropin‐releasing hormone agonist in the treatment of symptomatic endometriosis via openalex
THE NON‐SURGICAL TREATMENT OF ENDOMETRIOSIS BY PROGESTOGENS via openalex
The place of GnRH agonists in the treatment of endometriosis and fibroids by advanced endoscopic techniques via openalex
The use of newer progestins in the treatment of endometriosis via openalex
Three new synthetic progestins in the treatment of endometriosis. via openalex
Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. via openalex
W6719553514 via openalex
W1965145195 via openalex
W2412454843 via openalex
W1512318310 via openalex
W2417044776 via openalex
W2472762831 via openalex
W2477008945 via openalex
W170259557 via openalex
W6600720097 via openalex
W6714620062 via openalex

Source provenance

openalex: last seen: 2026-06-04T00:00:01.174412+00:00
unpaywall: last seen: 2026-06-02T02:00:03.124865+00:00

License: CC0 · commercial use OK

[1] 10 LHRH analogues in the treatment of endometriosis—comparative results with other treatments via openalex

[2] A comparison of nafarelin acetate and danazol in the treatment of endometriosis via openalex

[3] A Comparison of Plasma Protein Changes Induced by Danazol, Pregnancy, and Estrogens* via openalex

[4] A comparison of the efficacy and safety of buserelin vs danazol in the treatment of endometriosis. Protocol 310 Study Group. via openalex

[5] Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex

[6] A randomized double-blind prospective trial of two doses of gestrinone in the treatment of endometriosis via openalex

[7] Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: A randomized clinical trial via openalex

[8] Comparison of different treatment modalities of endometriosis in infertile women via openalex

[9] Comparison of different treatment modalities of endometriosis in infertile women. via openalex

[10] Conservative management of endometriosis: follow-up observations of progestin therapy. via openalex

[11] Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosis via openalex

[12] Deficient cellular immunity in endometriosis via openalex

[13] DYDROGESTERONE AND ENDOMETRIOSIS via openalex

[14] Evaluation of oral medroxyprogesterone acetate in the treatment of endometriosis. via openalex

[15] Hormone treatment of endometriosis: The estrogenthreshold hypothesis via openalex

[16] Impact of gestrinone on the course of asymptomatic endometriosis. via openalex

[17] Intranasal treatment with luteinising hormone releasing hormone agonist in women with endometriosis. via openalex

[18] Is It Possible to Prevent Bone Loss in Young Women Treated with Luteinizing Hormone-Releasing Hormone Agonists? via openalex

[19] Leuprorelin acetate depot vs danazol in the treatment of endometriosis: results of an open multicentre trial. via openalex

[20] MANAGEMENT OF ENDOMETRIOSIS WITH ORAL MEDROXYPROGESTERONE ACETATE via openalex

[21] Management of pelvic endometriosis with low-dose danazol via openalex

[22] Management of Pelvic Endometriosis with Low-Dose Danazol via openalex

[23] “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex

[24] Placebo-controlled comparison of danazol and high-dose medroxyprogesterone acetate in the treatment of endometriosis via openalex

[25] Preliminary observations on the use of danazol in endometriosis compared to oestrogen/progestogen combination therapy. via openalex

[26] Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial via openalex

[27] Reduction of vasomotor symptoms and bone mineral density loss with combined norethindrone and long-acting gonadotropin-releasing hormone agonist therapy of symptomatic endometriosis: a prospective randomized trial. via openalex

[28] REVERSIBLE TRABECULAR BONE DENSITY LOSS FOLLOWING INDUCED HYPO‐OESTROGENISM WITH THE GnRH ANALOGUE BUSERELIN IN PREMENOPAUSAL WOMEN via openalex

[29] Some clotting factors in plasma during danazol therapy: free and total protein S, but not C4b-binding protein, are elevated by danazol therapy. via openalex

[30] Successful treatment of asymptomatic endometriosis: does it benefit infertile women? via openalex

[31] The effect of danazol on pulsatile gonadotropin secretion in women with endometriosis via openalex

[32] The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis via openalex

[33] The effects of combining norethindrone with a gonadotropin‐releasing hormone agonist in the treatment of symptomatic endometriosis via openalex

[34] THE NON‐SURGICAL TREATMENT OF ENDOMETRIOSIS BY PROGESTOGENS via openalex

[35] The place of GnRH agonists in the treatment of endometriosis and fibroids by advanced endoscopic techniques via openalex

[36] The use of newer progestins in the treatment of endometriosis via openalex

[37] Three new synthetic progestins in the treatment of endometriosis. via openalex

[38] Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. via openalex

[39] W6719553514 via openalex

[40] W1965145195 via openalex

[41] W2412454843 via openalex

[42] W1512318310 via openalex

[43] W2417044776 via openalex

[44] W2472762831 via openalex

[45] W2477008945 via openalex

[46] W170259557 via openalex

[47] W6600720097 via openalex

[48] W6714620062 via openalex